Clinical Trials Browser

Phase 2 × Interventional × Unresectable Locally Advanced Pancreatic Cancer × Clear all

NCT05346146 2022-04-26

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Phase 2 Unknown

Gastrointestinal

Unresectable Locally Advanced Pancreatic Cancer